Depression Drugs Market

• 7.1. Atypical antipsychotics
• 7.2. Serotonin-norepinephrine reuptake inhibitors
• 7.3. Selective serotonin reuptake inhibitors
• 7.4. CNS stimulants
• 7.5. Others (Benzodiazepines and miscellaneous antidepressants)

• 8.1. Major Depressive Disorder
• 8.2. Schizophrenia and bipolar I disorder (manic depression)
• 8.3. SSRI induced
• 8.4. Others (attention deficit hyperactivity disorder and anxiety disorders)

• 9.1. Hospital pharmacies
• 9.2. Retail pharmacies
• 9.3. Online pharmacies

• 10.1. North America
• 10.2. Europe
• 10.3. Asia Pacific
• 10.4. Latin America
• 10.5. Middle East & Africa

• 16.1. Otsuka Pharmaceutical Co., Ltd.
• 16.2. Eli Lilly and Company
• 16.3. Pfizer, Inc.
• 16.4. AstraZeneca plc.
• 16.5. Novartis AG
• 16.6. GlaxoSmithKline plc
• 16.7. Takeda Pharmaceutical Company Ltd
• 16.8. Sebela Pharmaceutical Inc.
• 16.9. Allergan USA, Inc.
• 16.10. Johnson & Johnson

Table 01: Opportunity Map, by Drug Class, 2021

Table 02: Opportunity Map, by Disease Type, 2021

Table 03: Opportunity Map, by Distribution Channel, 2021

Table 04: Global Market Size (US$ Mn) Forecast, by Drug Class, 2021 to 2031

Table 05: Global Market Size (US$ Mn) Forecast, by Disease Type, 2020 to 2031

Table 06: Global Market Size (US$ Mn) Forecast, by Distribution Channel, 2020 to 2031

Table 07: Global Market (US$ Mn) Forecast, by Region, 2020 to 2031

Table 08: North America Market Size (US$ Mn) Forecast, by Drug Class, 2020 to 2031

Table 09: North America Market Size (US$ Mn) Forecast, by Disease Type, 2020 to 2031

Table 10: North America Market Size (US$ Mn) Forecast, by Distribution Channel, 2020 to 2031

Table 11: North America Market Size (US$ Mn) Forecast, by Country, 2020 to 2031

Table 12: U.S. Market Size (US$ Mn) Forecast, by Drug Class, 2020 to 2031

Table 13: U.S. Market Size (US$ Mn) Forecast, by Disease Type, 2020 to 2031

Table 14: U.S. Market Size (US$ Mn) Forecast, by Distribution Channel, 2020 to 2031

Table 15: Canada Market Size (US$ Mn) Forecast, by Drug Class, 2020 to 2031

Table 16: Canada Market Size (US$ Mn) Forecast, by Disease Type, 2020 to 2031

Table 17: Canada Market Size (US$ Mn) Forecast, by Distribution Channel, 2020 to 2031

Table 18: Europe Market Size (US$ Mn) Forecast, by Drug Class, 2020 to 2031

Table 19: Europe Market Size (US$ Mn) Forecast, by Disease Type, 2020 to 2031

Table 20: Europe Market Size (US$ Mn) Forecast, by Distribution Channel, 2020 to 2031

Table 21: Europe Market Size (US$ Mn) Forecast, by Country, 2020 to 2031

Table 22: Germany Market Size (US$ Mn) Forecast, by Drug Class, 2020 to 2031

Table 23: Germany Market Size (US$ Mn) Forecast, by Disease Type, 2020 to 2031

Table 24: Germany Market Size (US$ Mn) Forecast, by Distribution Channel, 2020 to 2031

Table 25: France Market Size (US$ Mn) Forecast, by Drug Class, 2020 to 2031

Table 26: France Market Size (US$ Mn) Forecast, by Disease Type, 2020 to 2031

Table 27: France Market Size (US$ Mn) Forecast, by Distribution Channel, 2020 to 2031

Table 28: Italy Market Size (US$ Mn) Forecast, by Drug Class, 2020 to 2031

Table 29: Italy Market Size (US$ Mn) Forecast, by Disease Type, 2020 to 2031

Table 30: Italy Market Size (US$ Mn) Forecast, by Distribution Channel, 2020 to 2031

Table 31: Spain Market Size (US$ Mn) Forecast, by Drug Class, 2020 to 2031

Table 32: Spain Market Size (US$ Mn) Forecast, by Disease Type, 2020 to 2031

Table 33: Spain Market Size (US$ Mn) Forecast, by Distribution Channel, 2020 to 2031

Table 34: U.K. Market Size (US$ Mn) Forecast, by Drug Class, 2020 to 2031

Table 35: U.K. Market Size (US$ Mn) Forecast, by Disease Type, 2020 to 2031

Table 36: U.K. Market Size (US$ Mn) Forecast, by Distribution Channel, 2020 to 2031

Table 37: Rest of Europe Market Size (US$ Mn) Forecast, by Drug Class, 2020 to 2031

Table 38: Rest of Europe Market Size (US$ Mn) Forecast, by Disease Type, 2020 to 2031

Table 39: Rest of Europe Market Size (US$ Mn) Forecast, by Distribution Channel, 2020 to 2031

Table 40: Asia Pacific Market Size (US$ Mn) Forecast, by Drug Class, 2020 to 2031

Table 41: Asia Pacific Market Size (US$ Mn) Forecast, by Disease Type, 2020 to 2031

Table 42: Asia Pacific Market Size (US$ Mn) Forecast, by Distribution Channel, 2020 to 2031

Table 43: Asia Pacific Market Size (US$ Mn) Forecast, by Country, 2020 to 2031

Table 44: China Market Size (US$ Mn) Forecast, by Drug Class, 2020 to 2031

Table 45: China Market Size (US$ Mn) Forecast, by Disease Type, 2020 to 2031

Table 46: China Market Size (US$ Mn) Forecast, by Distribution Channel, 2020 to 2031

Table 47: Japan Market Size (US$ Mn) Forecast, by Drug Class, 2020 to 2031

Table 48: Japan Market Size (US$ Mn) Forecast, by Disease Type, 2020 to 2031

Table 49: Japan Market Size (US$ Mn) Forecast, by Distribution Channel, 2020 to 2031

Table 50: India Market Size (US$ Mn) Forecast, by Drug Class, 2020 to 2031

Table 51: India Market Size (US$ Mn) Forecast, by Disease Type, 2020 to 2031

Table 52: India Market Size (US$ Mn) Forecast, by Distribution Channel, 2020 to 2031

Table 53: Australia & New Zealand Market Size (US$ Mn) Forecast, by Drug Class, 2020 to 2031

Table 54: Australia & New Zealand Market Size (US$ Mn) Forecast, by Disease Type, 2020 to 2031

Table 55: Australia & New Zealand Market Size (US$ Mn) Forecast, by Distribution Channel, 2020 to 2031

Table 56: Rest of Asia Pacific Market Size (US$ Mn) Forecast, by Drug Class, 2020 to 2031

Table 57: Rest of Asia Pacific Market Size (US$ Mn) Forecast, by Disease Type, 2020 to 2031

Table 58: Rest of Asia Pacific Market Size (US$ Mn) Forecast, by Distribution Channel, 2020 to 2031

Table 59: Latin America Market Size (US$ Mn) Forecast, by Drug Class, 2020 to 2031

Table 60: Latin America Market Size (US$ Mn) Forecast, by Disease Type, 2020 to 2031

Table 61: Latin America Market Size (US$ Mn) Forecast, by Distribution Channel, 2020 to 2031

Table 62: Latin America Market Size (US$ Mn) Forecast, by Country, 2020 to 2031

Table 63: Brazil Market Size (US$ Mn) Forecast, by Drug Class, 2020 to 2031

Table 64: Brazil Market Size (US$ Mn) Forecast, by Disease Type, 2020 to 2031

Table 65: Brazil Market Size (US$ Mn) Forecast, by Distribution Channel, 2020 to 2031

Table 66: Mexico Market Size (US$ Mn) Forecast, by Drug Class, 2020 to 2031

Table 67: Mexico Market Size (US$ Mn) Forecast, by Disease Type, 2020 to 2031

Table 68: Mexico Market Size (US$ Mn) Forecast, by Distribution Channel, 2020 to 2031

Table 69: Rest of Latin America Market Size (US$ Mn) Forecast, by Drug Class, 2020 to 2031

Table 70: Rest of Latin America Market Size (US$ Mn) Forecast, by Disease Type, 2020 to 2031

Table 71: Rest of Latin America Market Size (US$ Mn) Forecast, by Distribution Channel, 2020 to 2031

Table 72: Middle East & Africa Market Size (US$ Mn) Forecast, by Drug Class, 2020 to 2031

Table 73: Middle East & Africa Market Size (US$ Mn) Forecast, by Disease Type, 2020 to 2031

Table 74: Middle East & Africa Market Size (US$ Mn) Forecast, by Distribution Channel, 2020 to 2031

Table 75: Middle East & Africa Market Size (US$ Mn) Forecast, by Country, 2020 to 2031

Table 76: GCC Market Size (US$ Mn) Forecast, by Drug Class, 2020 to 2031

Table 77: GCC Market Size (US$ Mn) Forecast, by Disease Type, 2020 to 2031

Table 78: GCC Market Size (US$ Mn) Forecast, by Distribution Channel, 2020 to 2031

Table 79: South Africa Market Size (US$ Mn) Forecast, by Drug Class, 2020 to 2031

Table 80: South Africa Market Size (US$ Mn) Forecast, by Disease Type, 2020 to 2031

Table 81: South Africa Market Size (US$ Mn) Forecast, by Distribution Channel, 2020 to 2031

Table 82: Israel Market Size (US$ Mn) Forecast, by Drug Class, 2020 to 2031

Table 83: Israel Market Size (US$ Mn) Forecast, by Disease Type, 2020 to 2031

Table 84: Israel Market Size (US$ Mn) Forecast, by Distribution Channel, 2020 to 2031

Table 85: Rest of Middle East & Africa Market Size (US$ Mn) Forecast, by Drug Class, 2020 to 2031

Table 86: Rest of Middle East & Africa Market Size (US$ Mn) Forecast, by Disease Type, 2020 to 2031

Table 87: Rest of Middle East & Africa Market Size (US$ Mn) Forecast, by Distribution Channel, 2020 to 2031

Figure 01: Global Market Size (US$ Mn), by Drug Class, 2021 (A)

Figure 02: Global Market Revenue (%), 2021 (A)

Figure 03: Global Market Size (US$ Mn) Forecast, 2020 to 2031

Figure 04: Market Value Share, by Drug Class (2021)

Figure 05: Market Value Share, by Disease Type (2021)

Figure 06: Market Value Share, by Distribution Channel (2021)

Figure 07: Market Value Share, by Region (2021)

Figure 08: Global Market Value Share, by Valence, 2021 and 2031

Figure 09: Global Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Atypical antipsychotics, 2021 to 2031

Figure 10: Global Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by SNRI, 2021 to 2031

Figure 11: Global Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by SSRI, 2021 to 2031

Figure 12: Global Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by CNS stimulants, 2021 to 2031

Figure 13: Global Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Others, 2021 to 2031

Figure 14: Global Market Value Share, by Disease Type, 2021 and 2031

Figure 15: Global Market Revenue (US$ Mn), by MDD, 2021 to 2025

Figure 16: Global Market Revenue (US$ Mn), by Schizophrenia and bipolar I disorder, 2021 to 2025

Figure 17: Global Market Revenue (US$ Mn), by SSRI induced, 2020 to 2031

Figure 18: Global Market Revenue (US$ Mn), by Others, 2020 to 2031

Figure 19: Global Market Value Share, by Distribution Channel, 2021 and 2031

Figure 20: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hospital pharmacies, 2020 to 2031

Figure 21: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Retail pharmacies, 2020 to 2031

Figure 22: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Online pharmacies, 2020 to 2031

Figure 23: Global Market Analysis, by Region, 2021 and 2031

Figure 24: North America Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020 to 2031

Figure 25: North America Market Value Share, by Drug Class, 2021 and 2031

Figure 26: North America Market Value Share, by Disease Type, 2021 and 2031

Figure 27: North America Market Value Share, by Distribution Channel, 2021 and 2031

Figure 28: North America Market Value Share, by Country, 2021 and 2031

Figure 29: Europe Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020 to 2031

Figure 30: Europe Market Value Share, by Drug Class, 2021 and 2031

Figure 31: Europe Market Value Share, by Disease Type, 2021 and 2031

Figure 32: Europe Market Value Share, by Distribution Channel, 2021 and 2031

Figure 33: Europe Market Value Share, by Country/Sub Region, 2021 and 2031

Figure 34: Asia Pacific Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020 to 2031

Figure 35: Asia Pacific Market Value Share, by Drug Class, 2021 and 2031

Figure 36: Asia Pacific Market Value Share, by Disease Type, 2021 and 2031

Figure 37: Asia Pacific Market Value Share, by Distribution Channel, 2021 and 2031

Figure 38: Asia Pacific Market Value Share, by Country/Sub Region, 2021 and 2031

Figure 39: Latin America Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020 to 2031

Figure 40: Latin America Market Value Share, by Drug Class, 2021 and 2031

Figure 41: Latin America Market Value Share, by Disease Type, 2021 and 2031

Figure 42: Latin America Market Value Share, by Distribution Channel, 2021 and 2031

Figure 43: Latin America Market Value Share, by Country, 2021 and 2031

Figure 44: Middle East & Africa Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020 to 2031

Figure 45: Middle East & Africa Market Value Share, by Drug Class, 2021 and 2031

Figure 46: Middle East & Africa Market Value Share, by Disease Type, 2021 and 2031

Figure 47: Middle East & Africa Market Value Share, by Distribution Channel, 2021 and 2031

Figure 48: Middle East & Africa Market Value Share, by Country/Sub Region, 2021 and 2031

Figure 49: Sales Analysis, 2016 to 2020

Figure 50: Market Share, by Company, 2021